RITONAVIR

Course overview

RITONAVIR IS A PROTEASE INHIBITOR USED FOR THE TREATMENT OF HIV/AIDS. IT IS SELDOM EMPLOYED FOR ITS OWN ANTIVIRAL ACTIVITY BUT INSTEAD SERVES AS A BOOSTER FOR OTHER PROTEASE INHIBITORS. ALTHOUGH RITONAVIR WAS INITIALLY DESIGNED TO INHIBIT HIV PROTEASE, STUDIES HAVE FOUND THAT IT ALSO INHIBITS CYTOCHROME P450-3A4. BECAUSE OF ITS MECHANISM OF ACTION, RITONAVIR IS CURRENTLY UNDER INVESTIGATION FOR ITS USE IN TREATING SOME FORMS OF CANCER. IN ADDITION, IT IS USED IN COMBINATION WITH OTHER MEDICINES TO TREAT HEPATITIS C INFECTION. THIS ACTIVITY REVIEWS THE INDICATIONS, DOSAGE, ADMINISTRATION, ADVERSE EVENT PROFILE, MECHANISMS OF ACTION, TOXICITY, AND CONTRAINDICATIONS FOR RITONAVIR AS PART OF TREATING HIV/AIDS. THIS ACTIVITY IS PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM INVOLVED IN CARING FOR PATIENTS WITH HIV/AIDS, INCLUDING PHYSICIANS, INFECTIOUS DISEASE SPECIALISTS, NURSES, PHARMACISTS, PHYSICIAN ASSISTANTS, AND OTHER HEALTHCARE PROVIDERS.